Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 5/20 | 0.39 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HPGDS | O60760 | 1/20 | 0.37 |
| ▸ | KCNB1 | Q14721 | 2/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | SUV39H2 | Q9H5I1 | 1/20 | 0.35 |
| ▸ | Q9HBH1 | 1/20 | 0.35 | |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12516946 | 0.93 | KLKB1 (0.42) | MMP2KLKB1TSHRHPGDSKCNB1 | |
| SCHEMBL19445833 | 0.93 | KLKB1 (0.42) | MMP2KLKB1TSHRHPGDSKCNB1 | |
| SCHEMBL19445810 | 0.90 | KCNB1 (0.40) | MMP2KLKB1TSHRKCNB1HDAC1 | |
| SCHEMBL19445603 | 0.90 | KLKB1 (0.39) | MMP2KLKB1TSHRKCNB1HDAC1 | |
| SCHEMBL19445879 | 0.90 | KCNK3 (0.41) | MMP2KLKB1TSHRKCNB1HDAC1 | |
| SCHEMBL19445641 | 0.90 | ERAP2 (0.44) | MMP2KLKB1SUV39H2 | |
| SCHEMBL13977753 | 0.89 | KLKB1 (0.40) | MMP2KLKB1TSHRHPGDSKCNB1 | |
| SCHEMBL12779221 | 0.86 | ERAP2 (0.47) | MMP2KLKB1TSHRHPGDSSUV39H2 | |
| SCHEMBL19445695 | 0.85 | SUV39H2 (0.45) | MMP2KCNB1SUV39H2 | |
| SCHEMBL19944963 | 0.84 | HPGDS (0.48) | MMP2KLKB1TSHRHPGDSKCNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2709619-B1 | COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS | CELLCEUTIX CORP (US) | 2017-10-11 | — | — | EP | disclosed |